Skip to content
ppharmaranks
Menu
Class IIOngoing

Pemetrexed for Injection 100mg/Vial recall

FDA recall D-0671-2026 · initiated Jun 24, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jul 15, 2026How we research

Reliance Life Sciences Private Limited recalled Pemetrexed for Injection 100mg/Vial in Jun 2026 — an FDA Class II recall (D-0671-2026) because Lack of Sterility Assurance.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Lack of Sterility Assurance

Sterility could not be assured

The maker could not guarantee the product was sterile. That matters most for injections and eye products, where a contaminated dose reaches past the body's defences.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot, expiry: RPTL0325A Dec 31, 2027; RPTL0425A Dec 31, 2027; RPTL0624B Nov 30,2027; RPTL0625A Mar 31, 2028

Quantity recalled: 12,000 vials

Details

Product
Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01
Recalling company
Reliance Life Sciences Private Limited
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Jun 24, 2026
FDA report date
Jul 15, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Pemetrexed for Injection 100mg/Vial recalled?
Reliance Life Sciences Private Limited recalled Pemetrexed for Injection 100mg/Vial in Jun 2026 — an FDA Class II recall (D-0671-2026) because Lack of Sterility Assurance. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Pemetrexed for Injection 100mg/Vial recalled?
Per the FDA enforcement record, the reason for recall D-0671-2026 was: Lack of Sterility Assurance
Is a recalled Pemetrexed for Injection 100mg/Vial dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Pemetrexed for Injection 100mg/Vial are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot, expiry: RPTL0325A Dec 31, 2027; RPTL0425A Dec 31, 2027; RPTL0624B Nov 30,2027; RPTL0625A Mar 31, 2028. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0671-2026.

Source: openFDA Drug Enforcement record D-0671-2026

← All drug recalls